Received Feb 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
the other was only injected with the diluent.; the other was only injected with the diluent.; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a elderly male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received the 1st dose of Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: the other was only injected with the diluent.) and inappropriate dose of vaccine administered (Verbatim: the other was only injected with the diluent.). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date 20-FEB-2025 Other Healthcare Professionals reported that two customers came in to get vaccinated for RSV. Once customer received the properly mixed vaccine, the other was only injected with the diluent, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.